
NeuroTechR3 develops evidence-based exergame technologies to optimize rehabilitation outcomes for individuals with neurological diseases. Their solutions are affordable, engaging, and accessible for all ages, aiming to enhance overall wellness and quality of life. The company envisions becoming a leader in AI-driven, gamified rehabilitation, expanding digital health with reliable solutions for various neurological diseases like stroke, cerebral palsy, muscular dystrophy, autism, and ADHD. NeuroTechR3 is a women-owned company committed to advancing medical devices and technology to improve healthcare globally and serve as a role model for women in tech and business.

NeuroTechR3 develops evidence-based exergame technologies to optimize rehabilitation outcomes for individuals with neurological diseases. Their solutions are affordable, engaging, and accessible for all ages, aiming to enhance overall wellness and quality of life. The company envisions becoming a leader in AI-driven, gamified rehabilitation, expanding digital health with reliable solutions for various neurological diseases like stroke, cerebral palsy, muscular dystrophy, autism, and ADHD. NeuroTechR3 is a women-owned company committed to advancing medical devices and technology to improve healthcare globally and serve as a role model for women in tech and business.
Founded: 2020
Focus: Affordable telerehabilitation exergame system for neurological motor recovery
Notable award: NSF STTR Phase I grant ($256,000)
Headcount (approx.): 13 employees
Women-owned: Yes
Rehabilitation for neurological diseases (motor recovery after stroke, cerebral palsy, muscular dystrophy, autism, ADHD).
2020
Biotechnology
256000 USD
NSF STTR Phase I award to support R&D for a telerehabilitation system.
165000 USD
Recorded total funding indicates additional funding bringing total to $421,000 as of this date.
“NJEDA; National Science Foundation; U.S. Department of Health & Human Services”